Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Oct 14;11:517290. doi: 10.3389/fimmu.2020.517290

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2020 Heaton.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Global Pipeline, TB Vaccines for Adolescents & Adults (October 2019). SSI, Statens Serum Institut; TBVI, TuBerculosis Vaccine Initiative; ChadOx1/MVA, Chimpanzee Adenovirus, Oxford University #1 and Modified Vaccinia virus Ankara; PPE, family of Mtb genes; CMV-6Ag, cytomegalovirus vector expressing six Mtb antigens; OHSU, Oregon Health & Sciences University; CysVac2/Ad, Mtb fusion protein with novel adjuvant; ZMP, zinc metalloprotease deletion mutant; Ad5 Ag85A, human type 5 adenovirus vector expressing antigen 85A; GamTBVac, two Mtb fusion proteins with a novel adjuvant; MTBVAC, rationally attenuated Mtb clinical isolate; TB/Flu04L, live recombinant influenza vectored TB vaccine; BCG, Bacille Calmette-Guerin; IAVI, International AIDS Vaccine Initiative; ID93/GLA-SE, recombinant fusion protein in a lucopyranosyl lipid A stable emulsion; IDRI, Infectious Disease Research Institute; WT, Wellcome Trust; M72/AS01, recombinant fusion protein combined with the AS01 adjuvant system; GSK, GlaxoSmithKline; DAR-901, inactivated M. obuense; H56:IC31, recombinant fusion protein in a novel adjuvant; VPM1002, recombinant BCG; SII, Serum Institute of India; VPM, Vakzine Projekt Management GmbH; MIP, M. indicus pranii. Reprinted with permission from TuBerculosis Vaccine Initiative (12).